FDA Policy/General
FDA EDDO Control Strategy Guidance Analyzed
A Journal of Regulatory Affairs article written by staff from FDA and several drug companies analyzes an agency 2024 draft guidance on essential drug delivery outputs (EDDO) for devices intended to deliver drug and biological products, focusing on risk-based control strategies, effective submission strategies, and when to engage with